Table 2.

Comparison of mean [SD] laboratory data and predictive ratios (CAR–NLR–PLR–ELR) between no-recurrence, single recurrence, multiple recurrence, overall CRSsNP and control groups

	No recurrence	Single recurrence	Multiple recurrence	NP total	Control group	Multiple versus none p	Multiple versus single p	NP total versus control
Neutrophils	5.54 ± 0.93	6.03 ± 1.12	5.85 ± 0.82	5.76 ± 0.96	4.30 ± 1.16	0.225	0.353	0.02
Lymphocytes	2.26 ± 0.48	2.26 ± 0.42	2.21 ± 0.38	2.25 ± 0.43	2.38 ± 0.45	0.993	0.632	0.045
Eosinophils	0.53 ± 0.67	0.6 ± 0.65	0.78 ± 0.75	0.67 ± 0.70	0.22 ± 0.24	0.593	0.093	< 0.001**
Thrombocytes	279 ± 21.05	268.2 ± 32.4	282.3 ± 11.2	277.2 ± 23.01	291.6 ± 18.38	0.890	0.160	0.72
CRP	3.96 ± 1.30	6.67 ± 3.66	7.12 ± 5.13	5.55 ± 3.66	2.47 ± 0.43	0.02*	0.978	< 0.001**
Albumin	4.23 ± 0.47	4.23 ± 0.33	3.98 ± 0.55	4.16 ± 0.47	4.36 ± 0.28	0.72	0.186	0.58
CAR	0.92 ± 0.24	1.59 ± 0.92	1.74 ± 1.25	1.32 ± 0.89	0.56 ± 0.09	0.004*	0.955	< 0.001**
NLR	2.50 ± 0.45	2.71 ± 0.59	2,68 ± 0.41	2.60 ± 0.49	1.80 ± 0.42	0.183	0.789	< 0.001**
PLR	127.7 ± 24	125.2 ± 25.2	132.2 ± 22.4	128.2 ± 23.73	126.8 ± 24.8	0.826	0.136	0.747
ELR	0.25 ± 0.33	0.27 ± 0.35	0.34 ± 0.38	0.31 ± 0.33	0.09 ± 0.11	0.019*	0.249	< 0.001**

*p < 0.05; **p < 0.001